Published on 4 Apr 2024 on GuruFocus.com via Yahoo Finance
Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
President and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the company on April 2, 2024, according to a recent SEC filing. The transaction was executed at an average price of $26.25 per share, resulting in a total value of $735,000.
Avidity Biosciences Inc is a biotechnology company focused on the discovery and development of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs). The company aims to combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to target genetic drivers of disease.